Physiological Effect of Ataulfo Mango (Manguifera Indica) Beverage in Exercise

NCT03182543 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 19

Last updated 2017-06-09

No results posted yet for this study

Summary

The aim of this study is to assess the antioxidant capacity of two mango base beverages (AM1, AM2), against exercise-induced oxidative stress.

Conditions

  • Exercise-induced Oxidative Stress

Interventions

DIETARY_SUPPLEMENT

Mango pulp beverage

The subject consumes mango pulp beverage (200 g mango pulp + 600 mL water). 2 hours later subject performs the exercise test. Washout: 1 week washout period prior to the administration of this intervention to avoid possible carryover effect.

DIETARY_SUPPLEMENT

Mango pulp and peel beverage

The subject consumes mango pulp and peel beverage (160 g mango pulp + 40 g mango peel + 600 mL water). 2 hours later subject performs the exercise test. Washout: 1 week washout period prior to the administration of this intervention to avoid possible carryover effect.

DIETARY_SUPPLEMENT

Control beverage

The subject consumes control beverage (600 mL water). 2 hours later subject performs the exercise test. Washout: 1 week washout period prior to the administration of this intervention to avoid possible carryover effect.

Sponsors & Collaborators

  • Universidad Autonoma de Ciudad Juarez

    lead OTHER

Principal Investigators

  • Abraham Wall-Medrano, PhD · Universidad Autónoma de Ciudad Juárez

  • Gregorio Chavez-Treviño, MS · Universidad Autónoma de Ciudad Juárez

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
17 Years
Max Age
28 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-01-01
Primary Completion
2017-02-28
Completion
2017-04-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03182543 on ClinicalTrials.gov